Filter

Refine by Access

Refine by Date

—
  • Print
  • Save

Browse

You are looking at 151 - 160 of 3,806 items for

  • Refine by Access: All x
Clear All
Full access

HSR22-138: Oncologist’s Perceptions on Immune Checkpoint Inhibitor Therapies for Non-Small Cell Lung Cancer

Ricardo A Estupinian, Yolaine Jeune-Smith, Stephanie Fortier, Bruce Feinberg, and Ajeet Gajra

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-139: Augmented Intelligence to Reduce Oncology Care Model (OCM) Unplanned Admissions

Ajeet Gajra, Yolaine Jeune-Smith, Kelly Miller, Danielle Bergman, John Showalter, Nicholas Moffett, and Ray Page

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-140: Patient Preferences for Multi-Cancer Early Detection Tests: A Discrete Choice Experiment (DCE)

Heather Gelhorn, Melissa Ross, Anuraag R Kansal, Eric T Fung, Michael Seiden, Nicolas Krucien, and Karen C Chung

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-141: Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small Cell Lung Cancer Patients Without Actionable Genomic Alterations (AGAs) Previously Treated With Platinum-Based Chemotherapy and Immunotherapy

Jerome H Goldschmidt, Anupama Vasudevan, Michelle Silver, Jackie Kwong, and Elizabeth Marrett

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-142: A Review of Lung Cancer Screening Compliance in a Federally Qualified Health Center: Uncovering Unconscious Bias

Janeen Grant-Sittol, Rani Sittol, Latoya Gayle, Sharde Mcleish, Jodi-Ann Smith, Jason Lofters, Zachary Banbury, Natasha Rastogi, and Tanganyika Barnes

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-143: Outcome Differences Amongst Stage-Matched Inflammatory vs Non-Inflammatory Breast Cancer Patients

Michael Grimm, Kai Johnson, Patrick Schnell, Ashley Pariser, Margaret Gatti-Mays, Jeffrey VanDeusen, Nicole Williams, Daniel Stover, Sagar Sardesai, Robert Wesolowski, Preeti Sudheendra, Bhuvaneswari Ramaswamy, Ko Un Park, Sachin R Jhawar, Amy Kerger, and Mathew A Cherian

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-144: Survival Difference of EGFR Exon 19 Deletion and Exon 21 Mutation in Asian Patients With Advanced Non-small Cell Lung Cancer

Dawn Lynn P Guardiario, Gerardo H. Cornelio, and Raiza S. Marave

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-145: Pembrolizumab Plus Chemotherapy for First-Line Treatment of Advanced Triple-Negative Breast Cancer – A Network Meta-Analysis

Amin Haiderali, Min Huang, Wilbur Pan, Grace Fox, Dylan Maciel, and Andrew Frederickson

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-146: Health Utility in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC

Min Huang, Amin Haiderali, Peter Hu, Chaudhuri Mitashri, and Wilbur Pan

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

HSR22-147: Experiences of Patients (pts) With Metastatic Breast Cancer (mBC) During the COVID-19 Pandemic in the United States: Results of the Rethink Access to Care & Treatment (REACT) Survey

Neil Iyengar, Clay Williams, Michael Rogan, Laurie Campbell, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K. Kurosky, and Timothy Pluard

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022